Cargando…
A review on mortality risks associated with antipsychotic use in behavioral and psychologic symptoms of dementia (BPSD)
INTRODUCTION: As the population ages, the prevalence rate of behavioral and psychologic symptoms of dementia (BPSD) rises, and there appears to be an increasing need for pharmacologic treatment where nonpharmacologic treatment would not suffice. Most clinicians are well aware of the increased risks...
Autores principales: | Hui, Thng Shu, Wong, Agnes, Wijesinghe, Ruki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007591/ https://www.ncbi.nlm.nih.gov/pubmed/29955473 http://dx.doi.org/10.9740/mhc.2016.09.215 |
Ejemplares similares
-
Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): a qualitative study
por: Maidment, Ian D, et al.
Publicado: (2016) -
Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Liperoti, Rosa, et al.
Publicado: (2008) -
Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
por: Calsolaro, Valeria, et al.
Publicado: (2021) -
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
por: Ohno, Yukihiro, et al.
Publicado: (2019) -
Editorial: Pharmacology of BPSD (Behavioral and Psychological Symptoms of Dementia)
por: Giménez-Llort, Lydia, et al.
Publicado: (2021)